Back

Medscape, LLC

  • Breast Neoplasms

Communicating to Enhance Care Through Data and the Patient Experience: ER-Positive/HER2-Negative Metastatic Breast Cancer Edition

The goal of this activity is for learners to be better able to communicate regarding the management of patients with ER-positive/HER2-negative MBC who have recurred or progressed on AI CDK4/6 inhibitors.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Nov 20, 2025
  • Last day to claim credit
    Nov 21, 2026 6 weeks left